NEW YORK—GCI Group has promoted two of its senior healthcare executives, strengthening the leadership of the firm’s largest practice. Bill Martin has been named to the new position of executive vice president and North American practice leader and Jill Dosik has been named executive vice president and director of New York healthcare.
In their new roles, Martin and Dosik will be responsible for leading the next phase of growth by leveraging GCI’s already solid healthcare reputation and driving synergies across the New York, Atlanta, Toronto, Chicago and Los Angeles operations. AnnaMaria DeSalva continues in her role as executive vice president and worldwide managing director of GCI Healthcare.
Martin joined GCI in January 2004 and has sevred as senior strategic counsel to clients such as Merck, Cephalon and Endo. Dosik, a GCI veteran of 13 years, has counseled pharmaceutical and biotech brands in such areas as oncology, neuroscience and ophthalmology.